Venus MedTech Hangzhou Inc. has provided an update regarding ongoing patent litigation in the United States. On January 14, 2026, Cardiovalve Ltd. and MTH IP, L.P. filed a patent infringement lawsuit against Edwards Lifesciences in the United States District Court for the District of Delaware. The case concerns the alleged infringement of the US patent 10,702,385, which covers an implant for heart valves and is owned by Cardiovalve Ltd. The lawsuit follows a June 2025 decision by the US Court of Appeals for the Federal Circuit affirming the patentability of certain claims of this patent, after they were challenged by Edwards Lifesciences in an inter partes review. Venus MedTech has advised its shareholders and potential investors to exercise caution in dealings related to its shares while the litigation is ongoing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Venus MedTech HangZhou Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260122-11997951), on January 22, 2026, and is solely responsible for the information contained therein.